BRAF and colorectal cancer: Regarding BRAF mutations, 56% (14/25) of colorectal cancer with BRAF V660E mutation (BRAFV600E-CRC) were infected with Fn whereas significantly fewer of the colorectal cancers with wild-type BRAF (non-BRAFV600E-CRC; 34%: 95/279) were infected with Fn (OR: 2.39, P = 0.04; Table 1).